Viewing Study NCT03150004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-03-19 @ 9:40 PM
Study NCT ID: NCT03150004
Status: TERMINATED
Last Update Posted: 2025-03-26
First Post: 2017-05-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients with Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Sponsor: Medical College of Wisconsin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute myeloid leukemia View
None AML View
None salvage chemotherapy View
None CLAG-M View
None relapse acute myeloid leukemia View
None secondary acute myeloid leukemia View
None phase II View
None pharmacogenomics View
None myelodysplastic syndrome View